Ecovyst Q2 Sales Surge 42%, Raises Full-Year Outlook on Strong Demand and Calabrian Acquisition

summarizeSummary

Ecovyst reported Q2 2026 sales of $250 million, up 42% year-over-year, and raised full-year Adjusted EBITDA guidance to $195-$207 million, driven by strong demand and the Calabrian acquisition.

check_boxKey Events · Earnings and Guidance · ECVT

• Q2 Sales Surge 42%

  Sales reached $250.0 million, up $73.9 million from $176.1 million in Q2 2025, driven by higher volumes and pricing in both regenerated and virgin sulfuric acid.

• Adjusted EBITDA Up 27%

  Adjusted EBITDA rose to $53.1 million from $41.9 million, with margin of 21.2%, reflecting strong operating leverage and favorable net pricing.

• Full-Year Guidance Raised

  2026 Adjusted EBITDA guidance increased to $195-$207 million (from $180-$195 million), including $10-$12 million from Calabrian in H2; Adjusted Diluted EPS now seen at $0.58-$0.72.

• Calabrian Acquisition Completed

  The $190 million Calabrian deal closed June 30, 2026, expanding Ecovyst's sulfur dioxide platform into mining, water treatment, and pharma; integration synergies expected.

auto_awesomeAnalysis · ECVT · Industrial Applications And Services

A standout quarter saw sales jump 42% to $250 million, beating consensus, while full-year Adjusted EBITDA guidance was raised by $15 million at the midpoint. The performance reflects robust demand for regenerated and virgin sulfuric acid, plus the first contribution from the newly acquired Calabrian business. With $176 million in liquidity and no share repurchases during the quarter, the company is preserving cash for integration and growth. This is a clear positive signal that the core business is accelerating and the Calabrian deal is already adding value.